Lunit

Lunit Gross Margin

The Gross Margin of Lunit (328130.KQ) as of Oct 16, 2026 is 15.81 %. In the previous year, Gross Margin was 4.67 % — a change of 238.52% (higher).

Gross Margin

15.81 %

YoY

238.52%

Last updated:

Gross Margin of Lunit is 2024 15.81 % . Gross Margin of Lunit was 2023 4.67 % . It decreases by 238.52% higher compared to the previous year.

For Lunit, the gross margin of 15.8% is down versus 96.1% a few years ago.

The Lunit Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2020
96.09 KRW
Jan 1, 2021
88.54 KRW
Jan 1, 2022
10.46 KRW
Jan 1, 2023
4.67 KRW
Jan 1, 2024
15.81 KRW
The Lunit Gross Margin history
YEARGross MarginYoY
15.81 %+238.52%
4.67 %-55.36%
10.46 %-88.18%
88.54 %-7.85%
96.09 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lunit Stock analysis

What does Lunit do? Lunit Inc is a South Korean company headquartered in Seoul, operating within the Health Care sector. The company has 293 employees and went public on July 21, 2022, with its ticker listed as 328130.KQ and ISIN KR7328130000. Lunit provides software solutions for medical diagnostic imaging services, focusing on the development and supply of AI-powered medical software. Its offerings include cancer diagnostic aid solutions, cancer early detection solutions, and cancer risk prediction solutions. The company's technology leverages artificial intelligence to enhance diagnostic capabilities in healthcare settings. Lunit's website is www.lunit.io, where further information about its services and solutions can be accessed. The company operates in the Health Care industry, specifically targeting medical imaging and AI-driven diagnostic tools. As of the latest available data, Lunit is engaged in the development and commercialization of AI-based medical software, aiming to improve the accuracy and efficiency of cancer-related diagnostics. The firm's IPO date marks its transition to a publicly traded company, reflecting its growth and market position in the healthcare technology space. Lunit's focus on AI applications in medical imaging positions it as a key player in the digital health sector, particularly within the Korean market and beyond. The company's solutions are designed to support healthcare professionals in making more informed diagnostic decisions, potentially reducing the time and resources required for cancer detection and treatment planning. Lunit is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lunit stock

Gross Margin of Lunit is 15.81 % in 2024.

Gross Margin of Lunit changed from 4.67 % to 15.81 %, representing a 238.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Lunit since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Lunit with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Lunit

All Key Metrics — Lunit